Literature DB >> 10684753

Oestrogen and progesterone receptors in feline fibroadenomatous change: an immunohistochemical study.

J Martín De Las Mulas1, Y Millán, M J Bautista, J Pérez, L Carrasco.   

Abstract

The distribution of oestrogen and progesterone receptors was analysed in 18 cases of feline fibroadenomatous change (FFAC) using commercially available specific monoclonal antibodies and the Avidin-biotin peroxidase complex technique on formalin-fixed, paraffin-embedded tissue. In all cases of FFAC, progesterone receptors were detected either in epithelial cells (mostly suprabasal) or in epithelial and stromal cells. Oestrogen receptors were detected in approximately half of these cases, in suprabasal or luminal epithelial cells exclusively. Myoepithelial cells lacked both oestrogen and progesterone receptors. The techniques used have identified the specific cellular distribution of steroid hormones receptors in this hormone-dependent lesion of the feline mammary gland. The results confirm those of previous biochemical analyses with respect to progesterone receptors and add new data concerning the possible involvement of oestrogen receptors and stromal fibroblasts in the hormonal control and development of the lesion. Copyright 2000 Harcourt Publishers LtdCopyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10684753     DOI: 10.1053/rvsc.1999.0327

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  7 in total

1.  Mammary fibroadenomatous hyperplasia in a young cat attributed to treatment with megestrol acetate.

Authors:  Lori D MacDougall
Journal:  Can Vet J       Date:  2003-03       Impact factor: 1.008

2.  Precocious mammary development in an 8-month-old Holstein heifer.

Authors:  Divakar J Ambrose; Daya G V Emmanuel
Journal:  Can Vet J       Date:  2008-08       Impact factor: 1.008

3.  Mammary Fibroadenoma in Cats: A Matter of Classification.

Authors:  Filippo Torrigiani; Valentina Moccia; Barbara Brunetti; Francesca Millanta; Guillermo Valdivia; Laura Peña; Laura Cavicchioli; Valentina Zappulli
Journal:  Vet Sci       Date:  2022-05-26

4.  Conservative treatments for feline fibroadenomatous changes of the mammary gland.

Authors:  Gabriele Marino; Michela Pugliese; Fabiana Pecchia; Giuseppe Garufi; Vincenzo Lupo; Stefania Di Giorgio; Alessandra Sfacteria
Journal:  Open Vet J       Date:  2021-11-21

5.  Gynaecomastia in a male neutered cat with an adrenal tumour and associated hyperprogesteronism, hypercortisolism and hyperaldosteronism.

Authors:  Jane Yu; Jason Lenord; Michelle Lau; Laurencie Brunel; Rachael Gray; Shannon L Donahoe; Lara Boland
Journal:  JFMS Open Rep       Date:  2021-09-29

6.  Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas.

Authors:  Lorella Maniscalco; Yolanda Millán; Selina Iussich; Mauro Denina; Raquel Sánchez-Céspedes; Francesca Gattino; Bartolomeo Biolatti; Nobuo Sasaki; Takayuki Nakagawa; Maria Flavia Di Renzo; Juana Martín de Las Mulas; Raffaella De Maria
Journal:  BMC Vet Res       Date:  2013-04-15       Impact factor: 2.741

7.  Safety, tolerability, and pharmacokinetics of 6-month daily dosing of an oral formulation of cyclosporine (ATOPICA for cats®) in cats.

Authors:  E S Roberts; K A Vanlare; G Strehlau; M Peyrou; L M Roycroft; S King
Journal:  J Vet Pharmacol Ther       Date:  2013-10-18       Impact factor: 1.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.